Projects

HeartCHIP II will develop an automated optical analysis system for organ-on-chip cardiomyocyte contraction analysis

Organoids are superior novel tool to predict absorption, metabolism and toxicity in drug development

Better diagnosis, prognostics and treatment of retinal diseases by non-invasive measurements of retinal flow

Obruza does most of the work for regenerative medicine researchers through integrated automation

This study will define kidney donors which can be safely used for transplantation without risk of rejection

In this study the consortium will perform an external biomarker validation on fecal immunochemical test samples

With a novel high-throughput setup drugs will be found that increase relaxation in cardiac disease

Development of a safe erythrocyte alternative composed of nanocoated oxygen-generating micromaterials

“Bone-in-a-Box” represents a humanised in vitro model of bone regeneration

PT@LUMC aims to improve our knowledge of (non-)genetic factors contributing to variability in drug response